Intermittent Chemotherapy Is a Treatment Choice for Advanced Urothelial Cancer

Publisher： Karger

E-ISSN： 1423-0232|83|1|50-56

ISSN： 0030-2414

Source： Oncology, Vol.83, Iss.1, 2012-06, pp. : 50-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemotherapy in the Treatment of Advanced Gallbladder Cancer

By  

Oncology, Vol. 66, Iss. 2, 2004-05 ,pp. : 138-142

Karger

Access to resources Recommend Favorite

The Role of Neoadjuvant Chemotherapy in the Treatment of Advanced Ovarian Cancer

By  

Oncology, Vol. 68, Iss. 1, 2005-04 ,pp. : 64-70

Karger

Access to resources Recommend Favorite

Editorial Comment to Maintenance monotherapy with gemcitabine after standard platinum‐based chemotherapy in patients with advanced urothelial cancer

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 495-495

John Wiley & Sons Inc

Access to resources Recommend Favorite

Maintenance monotherapy with gemcitabine after standard platinum‐based chemotherapy in patients with advanced urothelial cancer

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 490-494

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preferences of Patients with Advanced Colorectal Cancer for Treatment with Oral or Intravenous Chemotherapy

By Mastroianni Candida M.  

The Patient: Patient-Centered Outcomes Research, Vol. 1, Iss. 3, 2008-01 ,pp. : 181-187

Adis International

Access to resources Recommend Favorite